Fundies.
English

BioXcel Therapeutics, Inc.

EDGAR
BTAI Current report (8-K) · filed 2026-10-30

Annual consolidated revenue for 2025: about Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 642K, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 2.266M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

182 thousand Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw

2026 Q2 · Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw

Exact inputs and evidence
  • Revenue: 182000 Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw Source

Operating margin

-5,600.55%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -10193000 Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw Source
  • Revenue: 182000 Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw Source
Cash and cash equivalents
12.8 million Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw Source
Exact value

12841000 Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw

Long-term debt including current maturities
104 million Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw Source
Exact value

104451000 Unit_Standard_USD_GatCVouVBkmjY6ldHJypmw

Shares outstanding
31.3 million Unit_Standard_shares_D0YgaeTrM0CTwLa-K0n8Dw Source
Exact value

31305000 Unit_Standard_shares_D0YgaeTrM0CTwLa-K0n8Dw

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2025-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -71.7%

    Prior period

    Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 2.27 million

    –

    Current period

    Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 642,000

    –

    Exact inputs and evidence

    642000 − 2266000 = -1624000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

    2266000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    642000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 10.3 million

    Prior period

    −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 59.6 million

    –

    Current period

    −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 69.9 million

    –

    Exact inputs and evidence

    -69897000 − -59599000 = -10298000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

    -59599000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -69897000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 14.41 million

    Prior period

    −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 72.03 million

    –

    Current period

    −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 57.62 million

    –

    Exact inputs and evidence

    -57615000 − -72027000 = 14412000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

    -72027000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -57615000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 0

    Prior period

    Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 0

    –

    Current period

    Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 0

    –

    Exact inputs and evidence

    0 − 0 = 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

    0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 642,000 100% of revenue
  • Cost of revenue Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 164,000 26% of revenue
  • Operating expenses Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 50.75 million 7,904% of revenue
  • Other operating costs Derived Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 194,000 30% of revenue
  • Operating income −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 50.46 million −7,860% of revenue
  • Tax, interest and other Derived Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 19.44 million 3,027% of revenue
  • Net income −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 69.9 million −10,887% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 57.62 million −8,974% of revenue
  • Capital expenditure Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 0 0% of revenue
  • Free cash flow Derived −Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 57.62 million −8,974% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 Operating loss: operating costs were 3,068% of revenue.
  • 2025 Operating loss: operating costs were 7,960% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-312266000 69511000 Derived -67245000 -7646000 Derived -59599000 -72027000 Derived
Source
2025 2025-01-01 – 2025-12-31642000 51103000 Derived -50461000 19436000 Derived -69897000 -57615000 Derived
Source

Amounts are exact, in Unit_Standard_USD_klpabqfCa0O0RmojqocB-g.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 642K 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.4M1.8M1.2M611.8K0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_klpabqfCa0O0RmojqocB-g)Source evidence
2024Revenue2266000
2025Revenue642000

Revenue growth

Change in revenue from the same financial period one year earlier.

-71.7% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6%-15%-36%-57%-77%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year-71.7%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7,860% 2025
Net margin -10,887.4% 2025
Free cash flow margin -8,974.3% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.871%-2,286%-5,444%-8,601%-11,758%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin-2,967.6%
2025Operating margin-7,860%
2024Net margin-2,630.1%
2025Net margin-10,887.4%
2024Free cash flow margin-3,178.6%
2025Free cash flow margin-8,974.3%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_klpabqfCa0O0RmojqocB-g -57.6M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.8M-15.1M-36.0M-56.9M-77.8M20242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_klpabqfCa0O0RmojqocB-g)Source evidence
2024Operating cash flow-72027000
2025Operating cash flow-57615000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_klpabqfCa0O0RmojqocB-g -57.6M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.8M-15.1M-36.0M-56.9M-77.8M20242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_klpabqfCa0O0RmojqocB-g)Source evidence
2024Free cash flow-72027000
2025Free cash flow-57615000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 59.6 million
Exact value

Exact value: -59599000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

2024-01-01 – 2024-12-31: -59599000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 72.03 million
Exact value

Exact value: -72027000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

2024-01-01 – 2024-12-31: -72027000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 0
Exact value

Exact value: 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

2024-01-01 – 2024-12-31: 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 72.03 million
Calculation and evidence

-72027000 − 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

Exact free cash flow: -72027000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 69.9 million
Exact value

Exact value: -69897000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

2025-01-01 – 2025-12-31: -69897000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 57.62 million
Exact value

Exact value: -57615000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

2025-01-01 – 2025-12-31: -57615000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 0
Exact value

Exact value: 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

2025-01-01 – 2025-12-31: 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_klpabqfCa0O0RmojqocB-g 57.62 million
Calculation and evidence

-57615000 − 0 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

Exact free cash flow: -57615000 Unit_Standard_USD_klpabqfCa0O0RmojqocB-g

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

49 filings · 3,465 latest values · 3,465 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001720893, 1720893, BTAI, BTAIQ, edgar:1720893

Also known as BioXcel Therapeutics, Inc.